Join to View Full Profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-384-9609
Fax+1 319-384-9613
Dr. Bellizzi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Andrew Bellizzi, MD, is a pathologist specializing in anatomic pathology, located in Iowa City, IA. After receiving his degree in Medicine from Northwestern University in 2004, he completed his residency in Pathology-Anatomic and Clinical at the University of Virginia Medical Center. He currently serves as a Clinical Professor at the University of Iowa Hospitals and Clinics, where he’s worked since 2011. Prior to that, he was an Associate Pathologist at Brigham and Women's Hospital and in Instructor at Harvard Medical School from 2009-2011. Dr. Bellizzi's areas of expertise comprise immunohistochemistry, gastrointestinal/hepatic pathology, biomarkers, and differential diagnosis. He has also published multiple research papers on various subjects in esteemed medical journals.
Education & Training
University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
Northwestern University The Feinberg School of MedicineClass of 2004
Certifications & Licensure
IA State Medical License 2011 - 2026
MA State Medical License 2009 - 2012
OH State Medical License 2008 - 2009
VA State Medical License 2004 - 2008
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- Neuroendocrine Tumor-Associated Chromogranin A Tubulopathy.Udhayvir Singh Grewal, Naomi Fei, Chandrikha Chandrasekharan, Andrew Bellizzi, Sanjeev Sethi
The American Journal of Medicine. 2025-06-01 - Optimal Approaches to Grading Enteropancreatic Neuroendocrine Tumors Using Ki-67 Proliferation Index: Hotspot and Whole-Slide Digital Quantitative Analysis.Ibrahim Abukhiran, Azfar Neyaz, Michaela Kop, Ihsan Baroudi, Daniel Christensen
Modern Pathology. 2025-04-15 - ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.Luis C Borbon, Scott K Sherman, Patrick J Breheny, Chandrikha Chandrasekharan, Yusuf Menda
Annals of Surgical Oncology. 2025-02-01
Press Mentions
AP Lab Panel on LDTs, Digital Path, WorkforceAugust 3rd, 2024- In Coag Collections, Every Detail CountsSeptember 17th, 2021
UI Neuroendocrine Tumor Program Earns High European DistinctionMarch 11th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
